August 27, 2014—Drug manufacturers are free to challenge the new 340B orphan drug exclusion "interpretative" rule, but they cannot do so as part of their successful lawsuit against the orphan drug "legislative" rule that came before, a federal district judge ruled this morning. … [Read more...]
Most Drugmakers Not Following HRSA’s 340B Orphan Drug Interpretive Rule
340B Prime Vendor says it is aware of "at least five" that are offering 340B pricingAugust 22, 2014—Most drugmakers reportedly are not extending 340B pricing on orphan drugs to rural and freestanding cancer hospitals despite the Health Resources and Services Administration's position that they are required by law to do so. … [Read more...]
Medicaid Drug Rebate Dispute Resolution Could Be Improved, OIG Says
CMS and HRSA reportedly are working on guidance regarding 340B-purchased drugsAugust 21, 2014—The Medicaid drug rebate program saved states and the federal government an average of $17.5 billion annually between 2011 and 2013, an amount that will grow as a result of changes made by the Affordable Care Act, the U.S. Health and Human Services Office of Inspector General says in a new report. … [Read more...]
Nonprofit Hospitals and Health Systems at a Financial “Tipping Point”
Median operating margin for systems fell to 2.2% in 2013 and is expected to decline further in 2014August 18, 2014—Nonprofit hospitals and health systems remained barely in the black in 2013 and signs point to even more financial pressure ahead, Standard & Poor's Ratings Services warned last week in two new reports. … [Read more...]
One-Third of Drugmakers Skipped Medicare Part B Price-Reporting Requirement
Failure might have resulted in incorrect payments to providers, OIG findsAugust 14, 2014—More than a third of drugmakers failed to submit average sales price data to the federal government for one or more of their Medicare Part B drugs during third quarter of 2012, despite being required to do so, the Department of Health and Human Services Office of Inspector General has found. … [Read more...]
Judge Repeats That Calif. 340B Medicaid Carve-Out Ban Is Invalid
State is appealing the decisionAugust 12, 2014—A federal district judge has reaffirmed that California health officials may not enforce a state law that forbids 340B health care providers from "carving out" 340B-purchased drugs from California's Medicaid program, Medi-Cal. State health care officials say they will appeal. … [Read more...]
Public Hospitals Provided $7.7 Billion in Uncompensated Care in 2012
America’s Essential Hospitals members report average operating loss of 0.4 percentAugust 7, 2014—Public hospitals and health systems – nearly all of which participate in the 340B program – provided more than $7.7 billion in uncompensated care in 2012, new data from the group America's Essential Hospitals show. The figure is about $1.7 billion greater than total amount spent on all drugs through the 340B program in 2012 by all types of health care providers. … [Read more...]